Cardiac Biomarker ST2 Identifies Chronic Heart Failure Patients To Benefit ... PharmaLive (press release) (subscription) “ST2 is unlike any biomarker in heart failure because of its enduring prognostic strength, but now, as evidenced by the encouraging results from this study, ST2 holds the final link in potentially improving outcomes for heart failure patients through ... |
